ROYCE CHARLES M

Charles M Royce sold 131,004 shares at $12.49–$12.54 across 3 sales for $1,639,681.09

Charles M Royce executed 3 separate sales totaling 131,004 shares for $1,639,681.09 on November 10–12, 2025, at prices ranging from $12.49 to $12.54—within 0.4% of the current price of $12.52. The sales reduced his holdings by 16.9%, from 775,279 shares to 644,275 shares. Across all his open-market history (7 prior sells), Royce has achieved a 90-day well-timed rate of 100.00%, with an average 90-day return of -15.3% after his sales, meaning the stock typically declined after he sold. This filing continues that pattern of prior timing success. The stock is currently 5.2% below its 52-week high of $13.20 and has risen 0.2% over the past 90 days, providing context for the execution prices relative to the asset's recent performance.

ROYCE CHARLES M sold 200,000 shares (200.0K shares) of RMT at $10.27 on 2025-11-05; 5 of 5 prior RMT sales were well-timed with negative 90d returns.

ROYCE CHARLES M executed a substantial sale of 200,000 shares at $10.27, reducing his holdings by 25.1% to 596,926 shares. Notably, this sale occurs within the context of a strong pattern: his prior 5 open-market sales at RMT were all well-timed, with each showing negative 90-day returns ranging from -6.4% to -17.9%, indicating the insider has consistently sold before subsequent declines. His cross-ticker track record reinforces this signal with a 100.00% well-timed rate across 6 prior sales (avg 90d return -15.3%). The current market shows RMT down 2.5% over 30 days and trading 5.4% below its 52-week high of $10.74, against the sale price of $10.27. This established pattern of prescient equity reductions by this insider warrants investor attention as a potential near-term bearish signal, though the stock remains within its 52-week range.

Royce Charles M sold 150,000 shares of RMT for $1,490,100.00 in 2 transactions at $9.97–$9.92

Royce Charles M executed two separate sales totaling 150,000 shares for $1,490,100.00 on 2025-02-18 and 2025-02-19, reducing his holdings by 13.4% from 1,120,942 shares to 970,942 shares. The blended average price of $9.93 sits near the current price of $9.94 and well below the 52-week high of $10.40, placing the sales in a recently declining market context (down 4.4% from peak). These two sales follow an immediate pattern of four consecutive insider sales at RMT on 2025-01-29, 2025-01-30, and 2025-01-31, suggesting concentrated selling activity within a three-week window. Without scheduled trading plan flags or additional context, the clustering of sales over a short period and the magnitude of position reduction (150K shares) merit monitoring for any broader signaling about the insider's conviction or liquidity needs.

Charles M. Royce sells 200,000 RMT shares across 4 transactions for $1,985,500.00; post-transaction holdings 1,120,942 shares

Charles M. Royce executed 4 separate sales totaling 200,000 shares for $1,985,500.00 at a blended average price of $9.93 across three consecutive trading days (January 29–31, 2025), reducing his holdings by 15.1% from 1,320,942 shares to 1,120,942 shares. The sales occurred when RMT traded near the middle of its 52-week range ($8.62–$10.40), with the current price of $9.80 now 1.3% below the blended sale price. As Chief Executive Officer of Royce Micro-Cap Trust, an investment trust vehicle, Royce's reduction in position represents a material divestiture of founder/leadership stake. The sustained multi-day execution and size (200K shares) warrants review of whether this reflects updated capital allocation plans or other material corporate considerations.